<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In traditional randomized controlled trial (RCT) designs, patients who are ineligible for randomization are excluded from study participation </plain></SENT>
<SENT sid="1" pm="."><plain>However, these patients often constitute an important subgroup of the disease population </plain></SENT>
<SENT sid="2" pm="."><plain>By extending existing RCT infrastructure, efforts to evaluate such patients in parallel cohort arms would provide an efficient means of generating multi-center prospective data on natural history, which would facilitate the development of future RCTs involving these subgroups of interest </plain></SENT>
<SENT sid="3" pm="."><plain>This brief report discusses principles of the parallel-cohort RCT design, describes the few published trials in which it has been employed, and highlights novel aspects of its use in the Kids-DOTT trial-an ongoing multi-center randomized trial of the duration of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in children </plain></SENT>
</text></document>